Navigation Links
U.S. Experts Still Unsure of Allergy Relief by Mouth

Medicines in droplet or pill form aren't yet ready to replace injections, physicians say

THURSDAY, Nov. 6 (HealthDay News) -- Even though orally delivered "sublingual immunotherapy" (SLIT) is used to treat allergies in a number of countries, there are unanswered questions about its effectiveness, appropriate use, dosage and safety of administration, according to experts at the annual meeting of the American College of Allergy, Asthma & Immunology (ACAAI), in Seattle.

SLIT -- a therapy considered investigational in the United States -- involves absorption of allergens into the body through the membranes of the mouth. Like traditional allergy injections, this is designed to help the body fight specific allergens.

"The main advantage of SLIT over traditional immunotherapy is patient convenience, since it is not an injection but oral drops or tablets that can be administered at home, and it appears to be safer than conventional immunotherapy," Dr. Ira Finegold, clinical professor of medicine at Columbia University and chairman of the R.A. Cook Institute of Allergy, St. Luke's-Roosevelt Hospital in New York, said in an ACAAI news release.

"Sublingual immunotherapy has gained wide acceptance in the treatment of allergic disease throughout Europe and South America, but the research studies in the United States have yet to show results that will convince the FDA to approve a product," Finegold said.

"We do not know the optimal dose for U.S. licensed allergen extracts for SLIT," added Dr. Linda Cox, assistant clinical professor of medicine at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Fla. "There is no consistent relationship between allergen dose and clinical efficacy. Each formulation including U.S. licensed extracts will need to demonstrate its effective dosing regimen."

She noted that since "SLIT treatment is administered at home with no direct medical supervision, the physician will need to provide specific instructions to patients on how to manage adverse reactions, unplanned treatment interruptions, situations in which the dose should be withheld, and dosing adjustments for any or all of these variables."

More information

The American Academy of Family Physicians has more about allergies.

-- Robert Preidt

SOURCE: American College of Allergy, Asthma & Immunology, news release, Nov. 6, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. USAID Sends Additional Earthquake Assistance and Team of Experts to Pakistan
2. Radiation Oncology Experts from 16 Countries Attend Technical University of Munich's International Conference on TomoTherapy
3. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
4. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
5. Children's National Experts Presenting at American Academy of Pediatrics Conference
6. Local Experts Help Women Living and Working with Cancer Even the Score
7. Save Money, Lives, and the Earth by Combining Conservation and Family Planning, Say Experts at World Conservation Congress
8. Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting, Oct. 25-29
9. PFCD Experts Cite Health Care as Next Financial Casualty on Horizon
10. Autism, Learning Disabilities and ADHD Experts Convene at the Help Group Summit
11. Accuracy, efficacy and ethics of abstinence-only programs questioned by public health experts
Post Your Comments:
Related Image:
U.S. Experts Still Unsure of Allergy Relief by Mouth
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: